Early diagnosis of Hantavirus, neuroinvasive Tick-borne encephalitis virus and follow-up of Lyme neuroborreliosis treatment (CXCL13)

Reagena Oy Ltd and Selinion Medical B.V. signed an exclusive distribution agreement for Benelux countries.

Reagena has appointed Selinion to distribute its range of zoonosis diagnostics products in the Netherlands, Belgium, and Luxemburg. Reagena has set new standards for the early diagnosis of Hantavirus, neuroinvasive Tick-borne encephalitis and Lyme neuroborreliosis (CXC13) virus by introducing state-of-the-art POCT technology with the highest possible diagnostic performances.